Peptides for skin: copper peptides, skincare and research peptides compared

Peptides are short chains of amino acids. In skincare the word covers a family of cosmetic ingredients added to creams and serums. A 2009 review of topical peptides for ageing skin sorted them into four groups: signal peptides, which are meant to prompt skin cells to make more collagen; carrier peptides, which deliver trace elements such as copper; enzyme-inhibitor peptides; and neurotransmitter-inhibitor peptides, which are meant to relax the small muscle movements behind expression lines ^[1].

So what do peptides do for skin? In cell cultures, several of these ingredients increase production of collagen and other parts of the skin's supporting matrix ^{[1] [6]}. Whether they do the same through intact skin, at the strength in a retail product, is a separate question, and the answer differs from one peptide to the next. The sections below take the main skin peptides in turn and say what kind of study each result came from.

This page is about evidence, not recommendations. Nothing here is medical advice, and none of the compounds discussed is an approved medicine for any skin condition.

Peptides skin care products and research peptides are different categories, even when they share a molecule. A copper peptide serum is a cosmetic: it is sold to be applied to the skin, its strength is set by the manufacturer, and it is regulated as a cosmetic rather than a medicine. The GHK-Cu sold in a vial by a peptide store is a freeze-dried powder labelled for research use, and it is marketed for injection. The same is true of glutathione, which is sold both as capsules and creams and as injectable vials.

The evidence does not transfer from one to the other. Every human result for GHK-Cu on skin comes from a topical product ^{[8] [9] [10]}. The injectable versions of GHK-Cu, KPV, epitalon and melanotan II have no controlled human trials for skin, and the FDA has raised concerns about immune reactions and impurities in several of them when compounded for injection ^[12]. For what the research-use label does and does not mean, see what research peptides are.

PepFinder tracks prices and testing for the research vials. It does not track retail skincare, and a listing here is not evidence that a product works or is legal to use.

Copper peptides for skin almost always means GHK-Cu, listed on cosmetic labels as copper tripeptide-1. GHK is a three-amino-acid peptide found naturally in human plasma, and reviews by its discoverer report that plasma levels fall from about 200 ng/mL at age 20 to about 80 ng/mL by age 60 ^[13]. That decline underpins much of the marketing, although a falling blood level does not show that applying GHK-Cu reverses anything.

The laboratory case is reasonable. In a 1988 study, GHK-Cu stimulated collagen synthesis in fibroblast cultures from very low concentrations, with a maximum effect at 10⁻⁹ M ^[6]. The clinical case is thin. A 2025 review of topical GHK as an anti-wrinkle ingredient found cell data supportive but described a surprising absence of clinical studies, and noted that getting a water-loving peptide through the outer layer of skin is a practical problem ^[7]. A 2026 systematic review found 20 eligible studies of GHK-Cu alone for aesthetic use, of which 18 were preclinical and only two were randomised controlled trials ^[8].

The human trials that do exist are small. In a 2006 randomised study of 13 patients after carbon dioxide laser resurfacing around the mouth, blinded assessment found no significant difference in redness, wrinkles or overall skin quality with GHK-Cu products, although patients using them reported higher satisfaction ^[9]. The strongest result is for wounds rather than wrinkles: in a 1994 randomised, placebo-controlled trial in diabetic foot ulcers, median closure of plantar ulcers was 98.5% with GHK-Cu gel against 60.8% with the gel base ^[10].

Penetration is the recurring issue. In a 2011 laboratory study using human skin, copper from a GHK-Cu solution passed through skin whose outer layer had been removed, with some retained in the tissue ^[11]. Both human trials above were on skin whose barrier was already broken, by a laser or an ulcer. Our GHK-Cu guide covers the wider literature, including hair and the topical versus injection question.

Palmitoyl pentapeptide-4, sold under the trade name Matrixyl, is the fatty-acid-linked form of the five-amino-acid peptide KTTKS. In a 12-week, double-blind, placebo-controlled, split-face trial in 93 women aged 35 to 55, a moisturiser containing 3 ppm of the peptide reduced wrinkles and fine lines more than the same moisturiser without it, on both instrument and expert grading, and it was well tolerated ^[2]. The study was carried out by researchers at Procter & Gamble, a skincare manufacturer. A 2011 review of KTTKS found a sound laboratory basis for its effect on collagen types I and III, but a surprising absence of skin penetration data and relatively few clinical studies ^[3].

Argireline (acetyl hexapeptide-3) is a neurotransmitter-inhibitor peptide modelled on part of the protein SNAP-25, which is part of the machinery nerve cells use to release chemical signals ^{[4] [5]}. In a 2013 randomised, placebo-controlled study, 60 Chinese adults applied argireline or placebo to the wrinkles around the eyes twice daily for four weeks; the argireline group had lower roughness measurements on silicone skin replicas, and 48.9% were judged improved against none in the placebo group ^[5]. Despite the comparison sometimes made with botulinum toxin, that study measured modest surface changes over four weeks, not muscle paralysis.

None of these signal peptides is sold in the research vials PepFinder tracks. They are included here because they are what many people mean by skin peptides, and because they show what a controlled cosmetic trial looks like.

Glutathione is a tripeptide antioxidant made in every cell. Laboratory work suggests it lowers melanin production by inhibiting the enzyme tyrosinase and by shifting pigment cells from dark eumelanin towards lighter phaeomelanin ^[22]. It is the most common compound marketed for skin whitening.

Oral and topical glutathione have small controlled trials. In a 2012 Thai trial, 60 medical students took 500 mg a day or placebo for four weeks; melanin fell at all six sites measured, and the difference from placebo was significant at two of them ^[14]. A 2017 trial of 250 mg a day for 12 weeks found melanin index and UV spots tended to be lower than placebo ^[15]. A 2025 systematic review found that oral glutathione reduced the melanin index against placebo in five randomised trials and that 0.5% topical glutathione beat placebo, but the only placebo-controlled intravenous trial showed a response in 6 of 16 people against 3 of 16 on placebo, which was not statistically significant ^[16].

Injectable glutathione for skin lightening has drawn regulator warnings. In 2015 the US FDA said it had not approved any injectable drug for skin whitening or lightening and warned that such products are unapproved and potentially unsafe ^[18]. The Philippine FDA warned in 2019 against injectable glutathione for skin lightening, listing possible liver, kidney and nerve toxicity, Stevens-Johnson syndrome, and infection from unsterile injection ^[19]. A 2025 case report described Stevens-Johnson syndrome and toxic epidermal necrolysis after an IV drip containing glutathione and vitamins ^[20], and in 2019 the FDA reported patients falling ill after injections compounded from supplement-grade glutathione powder contaminated with bacterial endotoxin ^[21]. Reviewers have also raised a theoretical, untested concern that shifting melanin towards the lighter type could reduce protection against sun damage ^[17]. The glutathione guide covers routes and trial doses in detail.

KPV is a three-amino-acid fragment (lysine-proline-valine) of the hormone alpha-MSH. It is studied as an anti-inflammatory, mainly in mouse colitis and in cells ^[23]. Its appeal for skin is that it appears to keep some of alpha-MSH's anti-inflammatory activity without the pigment effect.

The skin evidence is entirely from cells and animals. In a mouse model of allergic contact dermatitis, KPV applied to the skin or given systemically reduced the allergic reaction and induced tolerance to the allergen ^[24]. In 2025, KPV protected human skin cells in culture from damage caused by fine airborne dust, reducing oxidative stress and the inflammatory signal IL-1β ^[25]. Getting it into skin is a further hurdle: in a 2017 laboratory study, KPV did not pass through intact human skin by simple diffusion, and only crossed after the skin was pre-treated with microneedles ^[26].

No human trial of KPV has been published for skin or anything else, and the FDA has said it identified no human exposure data ^[12]. More detail is in the KPV guide, and KPV's place in multi-peptide vials is covered under Glow and Klow peptide blends.

Epitalon is a synthetic four-amino-acid peptide developed in Russia by V. Kh. Khavinson's group from the composition of a cattle pineal extract. Most of its research, which is mainly Russian animal and cell work, comes from that group and its collaborators ^[29]. It is marketed as an anti-ageing peptide because of a 2003 report that it switched on telomerase and lengthened telomeres in cultured human fibroblasts ^[27].

For skin specifically, the evidence is one laboratory study. In 2016 the same group reported that AEDG and related short peptides reduced an enzyme linked to tissue breakdown and increased markers of cell renewal in ageing skin fibroblasts in culture ^[28]. We found no human study of epitalon for skin appearance, wrinkles or elasticity. An independent 2025 study found that epitalon lengthened telomeres in normal human cells, and also in two breast cancer cell lines, which is relevant to any safety assessment ^[29]. The epitalon guide explains the telomerase claims and their limits.

Melanotan II is a synthetic cyclic analogue of alpha-MSH that stimulates pigment cells through the MC1 receptor. In the first human study, published in 1996, injections under the skin on alternate days for two weeks produced measurably darker skin in two of three men, along with nausea, yawning and spontaneous erections ^[30]. No larger controlled trials of melanotan II for tanning were published, and it has never been approved as a medicine anywhere.

Its safety record comes mainly from case reports of unsupervised use. A 2009 BMJ report linked changing moles to an unlicensed tanning injection ^[32]. A 2014 case described a 20-year-old woman diagnosed with melanoma after using melanotan II with sunbeds ^[33]. A 2017 review found four published cases of melanoma arising in existing moles during or shortly after melanotan use, while noting that conclusive evidence of cause and effect is lacking ^[31]. Many of these users also used sunbeds, so case reports cannot show how much risk the peptide itself adds.

Regulators have been direct. The UK's MHRA classes injectable melanotan II as a medicine that may not lawfully be sold without authorisation and advises anyone using it to stop ^[34]. Australia's TGA lists it as prescription-only and says supplying tanning products containing it without a prescription is illegal ^[35], and Health Canada named it among seized unauthorised peptides in 2026 ^[36]. The melanotan II guide and our melanotan 1 vs melanotan 2 comparison cover the approved relative, afamelanotide, and why it is a different product.

Claims about peptides for skin tightening usually rest on collagen: the idea that a peptide which raises collagen production in a dish will firm sagging skin. The controlled human evidence for anti aging peptides is almost all cosmetic and topical, and it measures fine lines and roughness rather than tightening. The palmitoyl pentapeptide trial reported fewer wrinkles and fine lines over 12 weeks ^[2], and the argireline trial reported smoother skin around the eyes over four weeks ^[5]. Neither measured skin laxity.

People looking for the best injectable peptides for skin tightening will not find a ranking in the research, because none of the injectable compounds has a controlled human trial for that purpose. Injected GHK-Cu has no published human trial of any kind. Epitalon's anti-ageing case rests on telomerase in cell culture and lifespan in mice ^{[27] [29]}. KPV has no human data ^[12]. Glutathione and melanotan II change skin colour, not firmness.

The same applies to lists of the best peptides for skin. The strongest controlled evidence for peptides for anti aging is for a few topical cosmetic ingredients in manufacturer-run or small trials, and it shows modest changes. Reviews of the field describe relatively few clinical studies ^{[1] [3]}.

There is no general answer, but the published trials give an idea of the timescales researchers used. The palmitoyl pentapeptide split-face trial reported its results at 12 weeks ^[2]. The argireline trial measured changes after four weeks of twice-daily use ^[5]. The GHK-Cu laser-resurfacing study assessed skin 12 weeks after treatment and found no objective difference from the comparison products at that point ^[9].

For glutathione, oral trials measured melanin after four weeks ^[14] and 12 weeks ^[15], and reviewers list how long any lightening lasts after stopping as an open question ^[16]. For melanotan II, darker skin was measured one week after a two-week course ^[30]. For KPV and epitalon there is no human timeline at all, because there are no human skin studies.

Week-by-week timelines on sales pages are not taken from these trials. Nor are before-and-after photographs, which cannot control for lighting, season, sun exposure or other products. In the GHK-Cu laser study, skin improved significantly in every patient whether or not they used GHK-Cu ^[9], which is why a comparison group matters.

In the small topical trials, the peptides studied were generally well tolerated: palmitoyl pentapeptide was described as well tolerated over 12 weeks ^[2], and in the GHK-Cu ulcer trial infections were less common with the peptide gel than with the gel base ^[10]. Those trials were short and used specific study products.

Online accounts of copper peptides causing breakouts, redness or peeling have not been studied in a controlled way, and we found no trial measuring how often retail copper peptide serums cause irritation. As a general point, any cosmetic ingredient can cause irritation or an allergic reaction in some people, and when several new products are started at once it is hard to tell which one was responsible. A reaction that does not settle is a reason to see a doctor or pharmacist.

For the injectable compounds the picture is different. The FDA has raised immune-reaction and impurity concerns for injectable GHK-Cu and epitalon, found no human exposure data for KPV, and lists published case reports of harm for melanotan II ^[12]. Glutathione injections have case reports of severe skin reactions and contamination with endotoxin ^{[20] [21]}. Melanotan II has case reports of mole changes and melanoma ^{[31] [32] [33]}. Any unlicensed injectable also carries the risk of wrong content and contamination; see third-party peptide testing.

Peptides in creams and serums are regulated as cosmetics rather than medicines. None of the five research compounds on this page is an approved medicine for any skin use.

In the US, the FDA previously placed injectable GHK-Cu, KPV, epitalon and melanotan II in category 2 of its compounding policy, the list of bulk substances that may present significant safety risks; the nominations were later withdrawn, which does not authorise their use ^[12]. The FDA has said it has not approved any injectable skin-lightening drug ^[18]. Health Canada's April 2026 advisory named GHK-Cu, KPV, epitalon and melanotan II among seized unauthorised peptides and said research-use labelling does not make them legal ^[36].

In the UK, the MHRA treats injectable melanotan II as an unauthorised medicine ^[34]. For how medicines law applies to research peptides in each country, see our legal status overview and the UK, US and Australia pages.

PepFinder does not sell peptides. It compares listings from the suppliers it tracks: GHK-Cu prices, glutathione prices, KPV prices, epitalon prices and melanotan II prices. Prices are easiest to compare per milligram, which our guide to peptide prices explains.

Because none of these products is regulated as a medicine, batch testing is the main check on what a vial contains. Our guides cover how to read a peptide COA and how to spot a fake peptide supplier, and the third-party tested suppliers list shows which vendors publish independent results. Our methodology explains how vendors are scored. A test result confirms identity and purity; it does not make an untested use safe.